Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $81.0500 (-8.58%) ($80.7000 - $81.0500) on Mon. May. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.57% (three month average) | RSI | 21 | Latest Price | $81.0500(-8.58%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -3.2% a day on average for past five trading days. | Weekly Trend | LGND declines -5.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(58%) IWC(55%) IWN(55%) | Factors Impacting LGND price | LGND will decline at least -1.785% in a week (0% probabilities). VIXM(-22%) UUP(-19%) VXX(-16%) TBT(-6%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.785% (StdDev 3.57%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $96.92 | 5 Day Moving Average | $90.06(-10%) | 10 Day Moving Average | $91.72(-11.63%) | 20 Day Moving Average | $96.92(-16.37%) | To recent high | -35.2% | To recent low | 0% | Market Cap | $1.303b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |